Dan Hutchins

Dan Hutchins

Editor

Dan graduated from Oxford Brookes University with a BA in History and Politics and the University of Cambridge with an MPhil in Political Thought and Intellectual History.

He has a professional background in scholarly and non-fiction publishing, working in editorial both on the history list at Bloomsbury Publishing Plc and within the major reference division at the Royal Pharmaceutical Society.  He has wide interdisciplinary interests, particularly where the humanities and the natural sciences intersect, but is above all exercised by the human capacity to construct and tell stories out of a complex world – and this is exactly what brings him to AzoNetwork.

In his spare time, Dan is an avid reader of both fiction and non-fiction, a keen walker and a hobbyist screenwriter.

Articles from Dan

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

How has the COVID-19 pandemic affected the mental health of older adults? A UK case study

How has the COVID-19 pandemic affected the mental health of older adults? A UK case study

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

COVID-19 pandemic underscores racial inequalities in US: a Michigan case study

COVID-19 pandemic underscores racial inequalities in US: a Michigan case study

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine for December 2020 roll out

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds